Variant:
rs1128503 at chr7:87179601 in ABCB1 (VIP)

Alleles (on + chromosomal strand)
A > G
Amino Acid Translation
Gly412Gly
Alternate Names:
ABCB1 1236C>T, ABCB1*8, ABCB1: c.1236T>C, ABCB1:1236C>T, ABCB1:1236T>C, Gly412Gly, c.1236T>A, c.1236T>C, c.1236T>G, g.167964T>A, g.167964T>C, g.167964T>G, g.25212444A>C, g.25212444A>G, g.25212444A>T, mRNA 1654T>C, p.Gly412Gly
Haplotypes
This variant is used to determine: ABCB1*13, ABCB1*13 (per Kroetz et al. 2003 [PMID: 12893986]), ABCB1*2 (per Kim et al. 2001 [PMID: 11503014]), ABCB1*2 (per Kroetz et al. 2003 [PMID: 12893986])

Clinical Annotations

To see the clinical annotation for this variant please register or sign in.

Variant Annotations

PharmGKB variant annotations provide information about variant-drug pairs based on individual PubMed publications. Each annotation represents information from a single paper and the goal is to report the information that the author states, not an interpretation of the paper. The PMID for supporting PubMed publications is found in the "Evidence" field.

Information presented, including study size, allele frequencies and statistics is taken directly from the publication. However, if the author does not correct p-values in cases of multiple hypotheses, curators may apply a Bonferroni correction. Curators attempt to report study size based on the actual number of participants used for the calculation of the association statistics, so the number may vary slightly from what is reported in the abstract of the paper. OMB Race Category information is derived from the paper and mapped to standardized categories. Category definitions may be found by clicking on the "OMB Race Category" link.

There are 29 annotations for this variant. Register or sign in to see them.

There are 3 disease-related annotations for this variant. Register or sign in to see them.

VIP Variant in ABCB1

Note: The ABCB1 gene is found on the minus chromosomal strand. Please note that for standardization, the PharmGKB presents all allele base pairs on the positive chromosomal strand, therefore the alleles within our variant annotations will differ (in a complementary manner) from those in this VIP summary that are given on the minus strand as reported in the literature.



A thymine (T) - cytosine © transition at nucleotide 1236 in exon 13 of ABCB1 (per ENST00000265724;vdb=variation;vf=10286490] in Ensembl) results in a synonymous change (GGT glycine, GGC glycine) at residue 412 in a cytoplasmic loop of the ATP-dependent membrane transporter, P-glycoprotein (P-gp) (see location per Fung et al. [Article:19285158] as adapted from Ambudkar et al. [Article:10331089]). This single nucleotide polymorphism (SNP) is one of three coding SNPs in ABCB1 with a high minor allele frequency; and the valence of the minor differs by ethnicity. According to dbSNP, the ancestral C allele ranges in frequency from 30% to 93% depending on the population, with C being the minor allele in Asians, and T being the minor allele in Africans.

Although many studies have studied potential phenotypic associations for this silent SNP, the literature bears no consensus [Article:16969364]. As a brief illustration, studies found increased drug exposure or drug response associated with the 1236 CC genotype [Article:18687982], the 1236 TT genotype [Articles:12960109, 18717915], or no genetic effect was found with regard to rs1128503 [Article:19207033].

The rs1128503 T allele is reference, and the C allele is non-reference, on the minus strand of the sequence in UCSC Genome browser (hg18), which is in the 5' to 3' orientation of the ABCB1 gene.

Key Publications:
Drugs / Other Molecules
Phenotype Datasets Pharmacokinetics of irinotecan in cancer patients

Appendix

Genomic Variant & GenBank ID: 84224 is reference A on AC005068 (hg18 plus strand)
mRNA Variant & GenBank ID: 1654 is reference T on NM_000927.3 (hg18 minus strand)
Protein Variant & GenBank ID: 412 is glycine on NP_000918.2 (hg18 minus strand) This synonymous SNP does not result in a variation in protein sequence.
GoldenPath Position: chr7:87017537 (hg18)

Positive and negative findings for drugs/substrates:

Drug/substrate Positive findings Negative findings
Cyclosporine A The TT genotype of this variant (1236 SNP) associated with increased drug levels in myasthenia gravis [Article:18717915]
Irinotecan and SN-38 TT genotype of this variant (1236 SNP) associated with increased drug exposure in cancer (PharmGKB data set: PA129966511) [Article:12960109]
Lopinavir This variant (1236 SNP) not associated with drug levels in HIV [Article:19207033]
Nelfinavir This variant (1236 SNP) marginally associated with increased drug response in HIV [Article:15651752]
Ritonavir This variant (1236 SNP) not associated with drug levels in HIV [Article:19207033]
Temozolomide The CC genotype of this variant (1236 SNP) associated with increased drug response in glioblastoma [Article:18687982]

Key Phenotypes/Diseases: Negative findings

Drug resistance: This variant (1236 SNP) not associated in drug response in pediatric epilepsy in Indians [Article:19571437]
Pediatric epilepsy: This variant (1236 SNP) not associated with disease risk in Indians [Article:19571437]
Systemic lupus erythematosus: This variant (1236 SNP) not associated with disease risk [Article:18820766]

ABCB1 haplotypes
Variant alleles in the common coding SNPs at nucleotides 1236 (rs1128503), 2677 (rs2032582), and 3435 (rs1045642) are in high linkage disequilibrium [Article:16708052], and are observed as common haplotypes in the population [Articles:11503014, 12893986, 19072639]. Variant alleles for 1236-2677-3435 commonly occur as the 893Ala-containing CGC haplotype and the 893Ser-containing TTT haplotype in most ethnic groups [Articles:11503014, 12172212, 12893986]. The vast majority of haplotypic studies for ABCB1 do not take into account all segregating sites that are used to distinguish ABCB1 star alleles (see below), but interrogate a select few variants.

ABCB1 star alleles
Sequence analysis of ABCB1 in different ethnic groups has been performed [Articles:11503014, 12172212, 12893986, 14646693, 15692830, 16708052, 17187507] and led to the designation of "star alleles" [Articles:14646693, 11503014, 12893986], as explained by Robarge et al. [Article:17700589]. ABCB1 star allele designations are currently not harmonized in the literature, and thus are specific to the citation referenced.

Connected Drugs

Connected Drug Classes

Evidence Drug Class
Variant Annotation
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
antiepileptics

Connected Diseases

Publications related to rs1128503 at chr7:87179601: 28

No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization. Pharmacogenomics. 2012. Hung Chin-Chuan, et al. [Article:22188362@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis. Clinical pharmacology and therapeutics. 2011. Herrlinger K R, et al. [Article:21289623@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis. Pharmacogenomics. 2011. Haerian Batoul Sadat, et al. [Article:21391884@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients. Pharmacogenomics. 2011. Hung Chin-Chuan, et al. [Article:21902500@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics. 2011. Santoro Ana, et al. [Article:21806386@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. Biochimie. 2010. Grover Sandeep, et al. [Article:20417680@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia. Leukemia research. 2010. Hartman A, et al. [Article:19467705@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients. Pharmacogenomics. 2010. Gonzalez-Haba Eva, et al. [Article:21142915@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients. Pharmacogenomics. 2010. Elens Laure, et al. [Article:20860463@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients. Pharmacogenomics. 2010. Wang Ping, et al. [Article:21047202@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. The pharmacogenomics journal. 2010. Gréen H, et al. [Article:20938465@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. The pharmacogenomics journal. 2010. Correia C T, et al. [Article:19997080@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2009. Rodríguez-Nóvoa Sonia, et al. [Article:19400747@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population. HIV medicine. 2009. Mahungu Tw, et al. [Article:19228205@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese. Pharmacogenomics. 2009. Kwan Patrick, et al. [Article:19450124@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel. The Laryngoscope. 2009. Grau Juan J, et al. [Article:19504558@PubMed]
No Dosing Guideline available No Drug Label available CA VA No VIP available No VIP available
ABCB1 polymorphisms may have a minor effect on ciclosporin blood concentrations in myasthenia gravis patients. British journal of clinical pharmacology. 2008. Zhang Ya-tong, et al. [Article:18717915@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Cancer science. 2008. Lal Suman, et al. [Article:18377430@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration. Pharmacogenetics and genomics. 2008. Aarnoudse Albert-Jan L H J, et al. [Article:18334914@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Substrate-dependent effects of human ABCB1 coding polymorphisms. The Journal of pharmacology and experimental therapeutics. 2008. Gow Jason M, et al. [Article:18287207@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. The Journal of rheumatology. 2008. Ranganathan Prabha, et al. [Article:18381794@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy research. 2007. Shahwan Amre, et al. [Article:17125969@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research. The pharmacogenomics journal. 2007. Leschziner G D, et al. [Article:16969364@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics. 2006. Seo Takayuki, et al. [Article:16753003@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics. Seizure : the journal of the British Epilepsy Association. 2006. Kim Young Ok, et al. [Article:16386926@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. The Journal of infectious diseases. 2006. Izzedine Hassane, et al. [Article:17083032@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population. Pharmacogenetics and genomics. 2005. Allabi Aurel C, et al. [Article:16220110@PubMed]
No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients. Investigational new drugs. 2004. Sparreboom Alex, et al. [Article:15122075@PubMed]

Cross-References

UCSC Golden Path:
chr7:87179601
dbSNP:
rs1128503
HapMap:
rs1128503
JSNP:
ssj0000017

Platform Availability

  • Illumina

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.